Pricing Log in Create free account

Iovance Biotherapeutics, Inc. (IOVA) vs Kodiak Sciences Inc. (KOD)

Iovance Biotherapeutics, Inc. and Kodiak Sciences Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $6.7B against $5.5B — 1.2× the size. Kodiak Sciences Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 13 metrics below, Iovance Biotherapeutics, Inc. leads on 7 and Kodiak Sciences Inc. on 6.

Valuation

Metric IOVA KOD Biotechnology median
P/E n/m n/m 8.50
P/S 18.81 n/m 9.71
P/B 8.31 87.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 17.90 n/m 9.21
Earnings yield (5.38%) (4.89%) (33.15%)
Free cash flow yield (4.85%) (2.98%) (25.50%)

Profitability

Metric IOVA KOD Biotechnology median
Gross margin 48.40% 0.00% 65.16%
Operating margin (92.72%) 0.00% 0.00%
Net margin (89.09%) 0.00% 0.00%
Free cash flow margin (91.21%) 0.00% 0.00%
Return on equity (40.36%) (368.37%) (56.36%)
Return on assets (31.76%) (94.25%) (48.04%)
Return on invested capital (42.96%) 0.00% 0.00%

Growth

Metric IOVA KOD Biotechnology median
Revenue growth (TTM) 34.55% — 6.02%
EPS growth (last fiscal year) 14.84% (28.96%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOVA KOD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.35 2.49 4.72
Net debt to EBITDA 0.82 1.01 0.96

Dividend

Metric IOVA KOD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IOVA KOD Biotechnology median
Market cap 6.67b 5.54b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack